Biotech | December 24, 2021
             
           Lecanemab granted Fast Track designation by the U.S. FDA
Alzheimer's disease is a serious, progressive and devastating disease with few treatment options
Alzheimer's disease is a serious, progressive and devastating disease with few treatment options
        Subscribe To Our Newsletter & Stay Updated